NASDAQ

Rallybio Corporation (RLYB)

♥ 588 Thanks from members

Live price chart, market sentiment, and community perspectives for Rallybio Corporation (NASDAQ: RLYB).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: Biotechnology / Rare DiseasesFounder: Younis BenabidFounder: Stephen PackerLeadership: Doug Treco (CEO)Leadership: Brian Riley (CFO)Holder: FMR LLCHolder: RA Capital ManagementHolder: Boxer CapitalRLY-2608 (PI3Kalpha mutant inhibitor)Complement InhibitorsRare Disease Therapeutics#RLYB#Rallybio#Rare Disease Biotech#Nasdaq RLYB#Clinical Stage Pharma